Design Therapeutics, Inc. DSGN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s enterprise value?
- Design Therapeutics, Inc. (DSGN) reported enterprise value of $646.16M in Q1 2026.
- How has Design Therapeutics, Inc.'s enterprise value changed year-over-year?
- Design Therapeutics, Inc.'s enterprise value increased by 211.3% year-over-year, from $207.58M to $646.16M.
- What is the long-term trend for Design Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s enterprise value has grown at a -12.7% compound annual growth rate (CAGR), from $893.48M to $519M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.